{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:19:46Z","timestamp":1787750386286,"version":"build-2784847793"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>\n                      Myopia is a complex refractive disorder and a leading cause of visual impairment worldwide. Inflammation plays a crucial role in the onset and progression of myopia. This study aimed to investigate the role of atropine in modulating inflammation-induced alterations in dopamine and its receptors in primary human scleral cells under\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      experimental conditions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Human primary scleral cells were exposed to long-term inflammatory conditions in the presence or absence of atropine or dopamine hydrochloride. Following treatment, gene and protein expressions were analyzed for inflammatory markers, dopamine receptors, and extracellular matrix (ECM) using quantitative polymerase chain reaction, immunoblotting, and immunofluorescence. Secretory cytokines and dopamine levels were measured using an automated enzyme-linked immunosorbent assay system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In primary human scleral cells, atropine treatment increases the dopamine receptor expression. Prolonged inflammatory stimulation led to a marked reduction in dopamine and its receptor (D1\u2013D2) expression, which was effectively restored following atropine treatment in scleral cells. Under inflammatory conditions, atropine significantly suppressed pro-inflammatory cytokines expression at both the transcript and protein levels and mitigated the inflammation-induced dysregulation of ECM genes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our findings demonstrate atropine restores inflammation-induced dopaminergic and extracellular matrix dysregulation in human scleral cells, highlighting its dual anti-inflammatory and neuro-modulatory roles. The restoration of dopamine signaling and ECM balance underscores atropine\u2019s potential as a therapeutic agent for myopia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_2901_25","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T16:04:58Z","timestamp":1782749098000},"page":"995-1003","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Atropine reinstates inflammation-induced dysregulation of dopamine and its receptors in human scleral cells: Implications for myopia therapy"],"prefix":"10.4103","volume":"74","author":[{"given":"Shivapriya","family":"Shivakumar","sequence":"first","affiliation":[{"name":"Grow Research Laboratory, Narayana Netralaya Foundation, Bangalore, Karnataka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithin","family":"Kiran","sequence":"additional","affiliation":[{"name":"Grow Research Laboratory, Narayana Netralaya Foundation, Bangalore, Karnataka"},{"name":"Faculty of Medicine and Life sciences, School of Mental Health and Neurosciences, Maastricht University, Maastricht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Shetty","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Life sciences, School of Mental Health and Neurosciences, Maastricht University, Maastricht, Netherlands"},{"name":"Department of Cornea and Refractive Surgery, Narayana Nethralaya Eye Hospital, Bangalore, Karnatake, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradhyumna Hulsermane","family":"Krishnamurthy","sequence":"additional","affiliation":[{"name":"Grow Research Laboratory, Narayana Netralaya Foundation, Bangalore, Karnataka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkasubhra","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Grow Research Laboratory, Narayana Netralaya Foundation, Bangalore, Karnataka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vrushali","family":"Deshpande","sequence":"additional","affiliation":[{"name":"Grow Research Laboratory, Narayana Netralaya Foundation, Bangalore, Karnataka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nallathambi","family":"Jeyabalan","sequence":"additional","affiliation":[{"name":"Grow Research Laboratory, Narayana Netralaya Foundation, Bangalore, Karnataka"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"R1-20260630","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"key":"R2-20260630","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"key":"R3-20260630","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ebiom.2016.07.021","article-title":"Role of chronic inflammation in myopia progression: Clinical evidence and experimental validation","volume":"10","author":"Lin","year":"2016","journal-title":"EBioMedicine"},{"key":"R4-20260630","doi-asserted-by":"crossref","first-page":"1260592","DOI":"10.3389\/fimmu.2023.1260592","article-title":"Effects of inflammation on myopia: Evidence and potential mechanisms","volume":"14","author":"Xu","year":"2023","journal-title":"Front Immunol"},{"key":"R5-20260630","first-page":"822","article-title":"[Dopamine receptors of the corneal epithelium and endothelium]","volume":"229","author":"Grub","year":"2012","journal-title":"Klin Monbl Augenheilkd"},{"key":"R6-20260630","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1167\/iovs.65.1.49","article-title":"Dopamine receptor 1 treatment promotes epithelial repair of corneal injury by inhibiting nod-like receptor protein 3-associated inflammation","volume":"65","author":"Li","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R7-20260630","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.3390\/cells12232730","article-title":"Modulating growth factor receptor signaling to promote corneal epithelial homeostasis","volume":"12","author":"Tarvestad-Laise","year":"2023","journal-title":"Cells"},{"key":"R8-20260630","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3390\/ijms19020464","article-title":"Role of corneal stromal cells on epithelial cell function during wound healing","volume":"19","author":"Kowtharapu","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R9-20260630","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1167\/iovs.62.4.14","article-title":"The dopaminergic neuronal system regulates the inflammatory status of mouse lacrimal glands in dry eye disease","volume":"62","author":"Ji","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R10-20260630","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1038\/s41433-025-03949-1","article-title":"Current and emerging strategies for myopia control: A narrative review of optical, pharmacological, behavioural, and adjunctive therapies","volume":"39","author":"Maulvi","year":"2025","journal-title":"Eye (Lond)"},{"key":"R11-20260630","doi-asserted-by":"crossref","first-page":"107774","DOI":"10.1016\/j.exer.2019.107774","article-title":"Cellular and cytoskeletal alterations of scleral fibroblasts in response to glucocorticoid steroids","volume":"187","author":"Bogarin","year":"2019","journal-title":"Exp Eye Res"},{"key":"R12-20260630","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/j.pain.0000000000001414","article-title":"Dopamine receptor D2, but not D1, mediates descending dopaminergic pathway-produced analgesic effect in a trigeminal neuropathic pain mouse model","volume":"160","author":"Liu","year":"2019","journal-title":"Pain"},{"key":"R13-20260630","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0161-6420(95)30872-X","article-title":"The novel dopamine D-1 antagonist and D-2 agonist, SDZ GLC-756, lowers intraocular pressure in healthy human volunteers and in patients with glaucoma","volume":"102","author":"Prunte","year":"1995","journal-title":"Ophthalmology"},{"key":"R14-20260630","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pharmthera.2010.05.003","article-title":"Pharmacology of signaling induced by dopamine D(1)-like receptor activation","volume":"128","author":"Undieh","year":"2010","journal-title":"Pharmacol Ther"},{"key":"R15-20260630","doi-asserted-by":"crossref","first-page":"34936","DOI":"10.1038\/srep34936","article-title":"The effect of topical atropine on the choroidal thickness of healthy children","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"R16-20260630","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1167\/iovs.15-16446","article-title":"Longitudinal changes in choroidal thickness and eye growth in childhood","volume":"56","author":"Read","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R17-20260630","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.exer.2007.02.019","article-title":"A muscarinic cholinergic antagonist and a dopamine agonist rapidly increase ZENK mRNA expression in the form-deprived chicken retina","volume":"85","author":"Ashby","year":"2007","journal-title":"Exp Eye Res"},{"key":"R18-20260630","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1017\/S0952523800171184","article-title":"Effects of atropine on refractive development, dopamine release, and slow retinal potentials in the chick","volume":"17","author":"Schwahn","year":"2000","journal-title":"Vis Neurosci"},{"key":"R19-20260630","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1017\/S0952523800012360","article-title":"Dopamine synthesis and metabolism in rhesus monkey retina: development, aging, and the effects of monocular visual deprivation","volume":"2","author":"Iuvone","year":"1989","journal-title":"Vis Neurosci"},{"key":"R20-20260630","doi-asserted-by":"crossref","first-page":"107737","DOI":"10.1016\/j.exer.2019.107737","article-title":"Serum metabolomics profiling and potential biomarkers of myopia using LC-QTOF\/MS","volume":"186","author":"Dai","year":"2019","journal-title":"Exp Eye Res"},{"key":"R21-20260630","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1038\/s41598-019-39652-x","article-title":"Inflammatory cytokines in highly myopic eyes","volume":"9","author":"Yuan","year":"2019","journal-title":"Sci Rep"},{"key":"R22-20260630","doi-asserted-by":"crossref","first-page":"155308","DOI":"10.1016\/j.cyto.2020.155308","article-title":"Proinflammatory and angiogenesis-related cytokines in vitreous samples of highly myopic patients","volume":"137","author":"Wei","year":"2021","journal-title":"Cytokine"},{"key":"R23-20260630","doi-asserted-by":"crossref","first-page":"510","DOI":"10.18240\/ijo.2022.03.21","article-title":"Scleral remodeling in myopia development","volume":"15","author":"Yu","year":"2022","journal-title":"Int J Ophthalmol"},{"key":"R24-20260630","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.bioeng.8.061505.095708","article-title":"Analysis of inflammation","volume":"8","author":"Schmid-Schonbein","year":"2006","journal-title":"Annu Rev Biomed Eng"},{"key":"R25-20260630","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/biomedicines8040078","article-title":"Atropine differentially modulates ECM production by ocular fibroblasts, and its ocular surface toxicity is blunted by colostrum","volume":"8","author":"Cristaldi","year":"2020","journal-title":"Biomedicines"},{"key":"R26-20260630","first-page":"157","article-title":"Role of Atropine in the control of myopia progression- A review","volume":"7","author":"Kaiti","year":"2022","journal-title":"Beyoglu Eye J"},{"key":"R27-20260630","first-page":"205","article-title":"Atropine reduces experimental myopia and eye enlargement via a nonaccommodative mechanism","volume":"34","author":"McBrien","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R28-20260630","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.etp.2015.07.006","article-title":"Cytotoxicity of atropine to human corneal epithelial cells by inducing cell cycle arrest and mitochondrion-dependent apoptosis","volume":"67","author":"Tian","year":"2015","journal-title":"Exp Toxicol Pathol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_2901_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:27:45Z","timestamp":1787747265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_2901_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_2901_25","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"2025-11-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}